News
Genetic Analysis AS: Publication of Annual Report 2023
Oslo, Norway, April 18, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the Annual Report for the…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 14 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…
Genetic Analysis AS: Mandatory notification of trade – Primary Insider
OSLO, NORWAY – 11 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management…
Year-end report January – December 2023
Oslo, Norway, February 29, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) hereby publishes the year-end report for the…
Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit
Oslo, Norway, November 26, 2024 – Genetic Analysis AS (the “Company”, Ticker: GEAN) is proud to announce that its GA-map®…
Meet Genetic Analysis at Medlab Middle East
Genetic Analysis is pleased to join the exhibitor list at Medlab Middle East 2024 in Dubai. The medical expo &…
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises
Genetic Analysis AS’ (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on December…
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis partners up to enter the consumer market with GA-map®
OSLO, NORWAY – December 21, 2023: Today, Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) announces a collaboration…
Genetic Analysis summarizes this year’s product development activities and looks ahead to 2024
OSLO, NORWAY – December 13, 2023: Today, the Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) publishes a…
How to use your subscription rights
Tradable subscription rights available until 22.12.2023 at 12: 00 CET Genetic Analysis AS has issued subscription rights (ticker: GEAN TR…
Today, the subscription period in Genetic Analysis subsequent offering begins
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…